Effervescent Floating Dosage Forms
GASTRORETENTIVE DOSAGE FORMS: REVIEW ON FLOATING DRUG DELIVERY SYSTEMS
7
BROMOCRIPTINE MESYLATE EFFERVESCENT FLOATING TABLETS
13
Formulation and evaluation of dipyridamole effervescent floating tablets
7
Formulation and in vitro evaluation of effervescent floating tablets of an antiulcer agent
8
FORMULATION AND EVALUATION OF GASTRORETENTIVE EFFERVESCENT FLOATING TABLETS OF DILTIAZEM HCl
22
FORMULATION AND IN VITRO EVALUATION OF FLOATING EFFERVESCENT TABLETS OF RANITIDINE HYDROCHLORIDE
10
Formulation Development and Evalua Tion of Fluoxetine Effervescent Floating Tablet
9
FORMULATION AND EVALUATION OF GASTRO RETENTIVE EFFERVESCENT FLOATING MATRIX TABLETS OF CEPHALEXIN
9
FORMULATION AND EVALUATION OF EFFERVESCENT FLOATING TABLET OF AMLODIPINE BESILATE WITH NATURAL POLYMER CHITOSAN
6
Formulation, In-Vitro and Ex-Vivo Evaluation of Non-Effervescent Floating Microparticulates of Celecoxib.
162
PREPARATION AND IN VITRO CHARACTERIZATION OF NON EFFERVESCENT FLOATING DELIVERY SYSTEM OF CEFPODOXIME PROXETIL
9
FORMULATION AND INVITRO EVALUATION OF NIFEDIPINE EFFERVESCENT FLOATING MATRIX TABLETS BY USING HYDROPHILIC POLYMERS
9
FORMULATION AND EVALUATION OF FLOATING EFFERVESCENT TABLETS OF RAMIPRIL
18
Comparative studies on Effervescent and Non-Effervescent Floating sustained release Matrix Tablets of Febuxostat
244
Dosage Forms
35
Abuse resistant dosage forms: A redress to modified release dosage forms
14
Paediatric Dosage Forms: A Review of Age Development and Dosage Forms of Choice
7
FORMULATION AND EVALUATION OF NON EFFERVESCENT FLOATING TABLETS OF CEFUROXIME AXETIL
12
DOSAGE FORMS AND STRENGTHS
31
Pharmaceutical Dosage Forms
51